Lista de obras -

A consultation on the optimization of controlled human malaria infection by mosquito bite for evaluation of candidate malaria vaccines

artículo científico publicado en 2012

A field trial to assess a blood-stage malaria vaccine

artículo científico publicado en 2011

Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults

artículo científico publicado en 2015

Antibodies to Peptides in Semiconserved Domains of RIFINs and STEVORs Correlate with Malaria Exposure

scholarly article by Albert E Zhou et al published 20 March 2019 in mSphere

Antibody Feedback Limits the Expansion of B Cell Responses to Malaria Vaccination but Drives Diversification of the Humoral Response

artículo científico publicado en 2020

Antigen-Specific B Memory Cell Responses to Plasmodium falciparum Malaria Antigens and Schistosoma haematobium Antigens in Co-Infected Malian Children ⬇️

artículo científico publicado el 5 de junio de 2012

Association of Schistosoma haematobium infection with protection against acute Plasmodium falciparum malaria in Malian children.

artículo científico publicado en 2005

Association of intraleukocytic Plasmodium falciparum malaria pigment with disease severity, clinical manifestations, and prognosis in severe malaria

artículo científico publicado en 2003

Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection

artículo científico publicado en 2017

Beyond Blood Smears: Qualification of Plasmodium 18S rRNA as a Biomarker for Controlled Human Malaria Infections.

artículo científico publicado en 2019

Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting

artículo científico publicado en 2007

Cell-mediated immunity elicited by the blood stage malaria vaccine apical membrane antigen 1 in Malian adults: results of a Phase I randomized trial

artículo científico publicado en 2009

Children with cerebral malaria or severe malarial anaemia lack immunity to distinct variant surface antigen subsets

artículo científico publicado en 2018

Controlled human malaria infections using aseptic, purified cryopreserved Plasmodium falciparum sporozoites administered by needle and syringe

artículo científico publicado en 2014

Corrigendum: Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

artículo científico publicado en 2016

Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria

artículo científico publicado en 2010

Differential recognition of terminal extracellular Plasmodium falciparum VAR2CSA domains by sera from multigravid, malaria-exposed Malian women

artículo científico publicado en 2015

Differential var gene transcription in Plasmodium falciparum isolates from patients with cerebral malaria compared to hyperparasitaemia

artículo científico publicado en 2006

Dose-Dependent Infectivity of Aseptic, Purified, Cryopreserved Plasmodium falciparum 7G8 Sporozoites in Malaria-Naive Adults

scientific article published on 01 November 2019

Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali

artículo científico publicado en 2007

Effects of concomitant Schistosoma haematobium infection on the serum cytokine levels elicited by acute Plasmodium falciparum malaria infection in Malian children

artículo científico publicado en 2006

Epitope-specific antibody responses to a Plasmodium falciparum subunit vaccine target in a malaria-endemic population

artículo científico publicado en 2020

Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trial

artículo científico publicado en 2013

HLA-A2 supertype-restricted cell-mediated immunity by peripheral blood mononuclear cells derived from Malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls

artículo científico publicado en 2005

Hemoglobin C Trait Provides Protection From Clinical Falciparum Malaria in Malian Children

artículo científico publicado en 2015

High levels of Plasmodium falciparum rosetting in all clinical forms of severe malaria in African children

artículo científico publicado en 2009

Host and Parasite Transcriptomic Changes upon Successive Plasmodium falciparum Infections in Early Childhood

scientific article published on 07 July 2020

Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02

article

Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali.

artículo científico publicado en 2002

Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease

artículo científico publicado en 2005

Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali

artículo científico publicado en 2004

Long-term Maintenance of CD4 T Cell Memory Responses to Malaria Antigens in Malian Children Coinfected with Schistosoma haematobium

artículo científico publicado en 2017

Low multiplication rates of African Plasmodium falciparum isolates and lack of association of multiplication rate and red blood cell selectivity with malaria virulence

artículo científico publicado en 2006

Malaria severity: Possible influence of the E670G PCSK9 polymorphism: A preliminary case-control study in Malian children

artículo científico publicado en 2018

Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination

scientific article published on 03 March 2020

Multidose Priming and Delayed Boosting Improve PfSPZ Vaccine Efficacy against Heterologous P. falciparum Controlled Human Malaria Infection

artículo científico publicado en 2020

Optimizing Intradermal Administration of Cryopreserved Plasmodium falciparum Sporozoites in Controlled Human Malaria Infection

artículo científico publicado en 2015

Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report

preprint

Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults

scientific article published on 12 August 2020

Plasmodium falciparum malaria challenge by the bite of aseptic Anopheles stephensi mosquitoes: results of a randomized infectivity trial

artículo científico publicado en 2010

Platelet-mediated clumping of Plasmodium falciparum infected erythrocytes is associated with high parasitemia but not severe clinical manifestations of malaria in African children

artículo científico publicado en 2007

Progress with PfSPZ Vaccine, a radiation attenuated Plasmodium falciparum sporozoite vaccine

artículo científico publicado en 2014

Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines

scientific article published on 12 October 2015

Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

artículo científico publicado en 2016

Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine

artículo científico publicado en 2013

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

artículo científico publicado en 2020

Reduced T Regulatory Cell Response during Acute Plasmodium falciparum Infection in Malian Children Co-Infected with Schistosoma haematobium ⬇️

artículo científico publicado el 14 de febrero de 2012

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

artículo científico publicado en 2020

Safety and Immunogenicity of an AS03B-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study

scientific article published on 27 April 2020

Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial

artículo científico publicado en 2006

Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial

artículo científico publicado en 2008

Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial

artículo científico publicado en 2010

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

artículo científico publicado en 2017

Serologic responses to the PfEMP1 DBL-CIDR head structure may be a better indicator of malaria exposure than those to the DBL-α tag

artículo científico publicado en 2019

Seroreactivity to Plasmodium falciparum erythrocyte membrane protein 1 intracellular domain in malaria-exposed children and adults

artículo científico publicado en 2013

Seroreactivity to a large panel of field-derived Plasmodium falciparum apical membrane antigen 1 and merozoite surface protein 1 variants reflects seasonal and lifetime acquired responses to malaria

artículo científico publicado en 2014

Serum antibody levels to glycosylphosphatidylinositols in specimens derived from matched Malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls.

artículo científico publicado en 2006

Steady progress toward a malaria vaccine

artículo científico publicado en 2017

Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate

artículo científico

Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential

scientific article published on 08 January 2020

Successful human infection with P. falciparum using three aseptic Anopheles stephensi mosquitoes: a new model for controlled human malaria infection

artículo científico publicado en 2013

The Controlled Human Malaria Infection Experience at the University of Maryland

scientific article published on 01 March 2019

Tracking human migrations by the analysis of the distribution of HLA alleles, lineages and haplotypes in closed and open populations

artículo científico publicado en 2012

Two complement receptor one alleles have opposing associations with cerebral malaria and interact with α+thalassaemia.

artículo científico publicado en 2018

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, doub

artículo científico publicado en 2015

Lista de obras de

A consultation on the optimization of controlled human malaria infection by mosquito bite for evaluation of candidate malaria vaccines

A field trial to assess a blood-stage malaria vaccine

Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults

Antibodies to Peptides in Semiconserved Domains of RIFINs and STEVORs Correlate with Malaria Exposure

Antibody Feedback Limits the Expansion of B Cell Responses to Malaria Vaccination but Drives Diversification of the Humoral Response

Antigen-Specific B Memory Cell Responses to Plasmodium falciparum Malaria Antigens and Schistosoma haematobium Antigens in Co-Infected Malian Children ⬇️

Association of Schistosoma haematobium infection with protection against acute Plasmodium falciparum malaria in Malian children.

Association of intraleukocytic Plasmodium falciparum malaria pigment with disease severity, clinical manifestations, and prognosis in severe malaria

Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection

Beyond Blood Smears: Qualification of Plasmodium 18S rRNA as a Biomarker for Controlled Human Malaria Infections.

Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting

Cell-mediated immunity elicited by the blood stage malaria vaccine apical membrane antigen 1 in Malian adults: results of a Phase I randomized trial

Children with cerebral malaria or severe malarial anaemia lack immunity to distinct variant surface antigen subsets

Controlled human malaria infections using aseptic, purified cryopreserved Plasmodium falciparum sporozoites administered by needle and syringe

Corrigendum: Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria

Differential recognition of terminal extracellular Plasmodium falciparum VAR2CSA domains by sera from multigravid, malaria-exposed Malian women

Differential var gene transcription in Plasmodium falciparum isolates from patients with cerebral malaria compared to hyperparasitaemia

Dose-Dependent Infectivity of Aseptic, Purified, Cryopreserved Plasmodium falciparum 7G8 Sporozoites in Malaria-Naive Adults

Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali

Effects of concomitant Schistosoma haematobium infection on the serum cytokine levels elicited by acute Plasmodium falciparum malaria infection in Malian children

Epitope-specific antibody responses to a Plasmodium falciparum subunit vaccine target in a malaria-endemic population

Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in malian children: 24-month follow-up of a randomized, double-blinded phase 2 trial

HLA-A2 supertype-restricted cell-mediated immunity by peripheral blood mononuclear cells derived from Malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls

Hemoglobin C Trait Provides Protection From Clinical Falciparum Malaria in Malian Children

High levels of Plasmodium falciparum rosetting in all clinical forms of severe malaria in African children

Host and Parasite Transcriptomic Changes upon Successive Plasmodium falciparum Infections in Early Childhood

Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02

Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali.

Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease

Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali

Long-term Maintenance of CD4 T Cell Memory Responses to Malaria Antigens in Malian Children Coinfected with Schistosoma haematobium

Low multiplication rates of African Plasmodium falciparum isolates and lack of association of multiplication rate and red blood cell selectivity with malaria virulence

Malaria severity: Possible influence of the E670G PCSK9 polymorphism: A preliminary case-control study in Malian children

Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination

Multidose Priming and Delayed Boosting Improve PfSPZ Vaccine Efficacy against Heterologous P. falciparum Controlled Human Malaria Infection

Optimizing Intradermal Administration of Cryopreserved Plasmodium falciparum Sporozoites in Controlled Human Malaria Infection

Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report

Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults

Plasmodium falciparum malaria challenge by the bite of aseptic Anopheles stephensi mosquitoes: results of a randomized infectivity trial

Platelet-mediated clumping of Plasmodium falciparum infected erythrocytes is associated with high parasitemia but not severe clinical manifestations of malaria in African children

Progress with PfSPZ Vaccine, a radiation attenuated Plasmodium falciparum sporozoite vaccine

Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines

Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

Reduced T Regulatory Cell Response during Acute Plasmodium falciparum Infection in Malian Children Co-Infected with Schistosoma haematobium ⬇️

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Safety and Immunogenicity of an AS03B-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study

Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial

Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial

Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

Serologic responses to the PfEMP1 DBL-CIDR head structure may be a better indicator of malaria exposure than those to the DBL-α tag

Seroreactivity to Plasmodium falciparum erythrocyte membrane protein 1 intracellular domain in malaria-exposed children and adults

Seroreactivity to a large panel of field-derived Plasmodium falciparum apical membrane antigen 1 and merozoite surface protein 1 variants reflects seasonal and lifetime acquired responses to malaria

Serum antibody levels to glycosylphosphatidylinositols in specimens derived from matched Malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls.

Steady progress toward a malaria vaccine

Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate

Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential

Successful human infection with P. falciparum using three aseptic Anopheles stephensi mosquitoes: a new model for controlled human malaria infection

The Controlled Human Malaria Infection Experience at the University of Maryland

Tracking human migrations by the analysis of the distribution of HLA alleles, lineages and haplotypes in closed and open populations

Two complement receptor one alleles have opposing associations with cerebral malaria and interact with α+thalassaemia.

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, doub